By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Gun GravyGun GravyGun Gravy
Notification Show More
Font ResizerAa
  • Home
  • Latest News
  • Firearms
  • Tactical
  • Videos
Reading: Russia’s Cancer Vaccine Administered To Melanoma Patient
Share
Font ResizerAa
Gun GravyGun Gravy
  • Latest News
  • Firearms
  • Tactical
  • Videos
Search
  • Home
  • Latest News
  • Firearms
  • Tactical
  • Videos
Have an existing account? Sign In
Follow US
Gun Gravy > Tactical > Russia’s Cancer Vaccine Administered To Melanoma Patient
Tactical

Russia’s Cancer Vaccine Administered To Melanoma Patient

Jim Flanders
Last updated: April 2, 2026 5:41 pm
Jim Flanders Published April 2, 2026
Share
SHARE

The Russian Ministry of Health announced yesterday that doctors at the National Medical Research Center for Radiology administered the country’s first domestically developed personalized mRNA-based cancer vaccine. The patient who received the vaccine is a 60-year-old melanoma patient.

Neooncovac, is the first domestically developed personalized mRNA-based cancer vaccine.

First Test Batches of Russia’s AI-assisted Cancer Vaccine Have Been Created

According to Doolly, his therapeutic vaccine, created using the patient’s unique tumor-specific mutations and molecular-genetic characteristics, works as an individualized anti-tumor treatment by encoding neoantigens into mRNA delivered via lipid nanoparticles. It trains the immune system to mount a targeted T-cell response against cancer cells while aiming to minimize harm to healthy tissue.

Neooncovac is authorized for adult patients with inoperable or metastatic cutaneous melanoma, often alongside immunotherapy.

Other countries have been looking into using artificial intelligence in order to create and test cancer vaccines.

UK Will Be The First to Trial BioNTech’s mRNA Cancer “Vaccines.”

mRNA “Vaccines” Facing Backlash?

Personalized cancer vaccines differ fundamentally from conventional preventive vaccines. They serve as therapeutic vaccines designed to treat existing disease by harnessing the patient’s immune system. The approach relies on identifying neoantigens—unique proteins generated by tumor-specific mutations present only in cancer cells. –Doolly

After the injection, the mRNA in the vaccine instructs the patient’s cells to produce neoantigens, then presents them to the immune system. This stimulates a targeted T-cell response and broader immune response, training the body to recognize and eliminate cancer cells bearing the same mutations. Because the vaccine focuses on patient-specific alterations, it aims to minimize effects on healthy tissue while potentially creating long-term immune memory against recurrence.

Russian researchers built on expertise gained from prior mRNA work, including platforms developed during the COVID-19 response.

Who Is At Fault When Americans Distrust COVID “Vaccines?” Russia, Of Course!

Many still don’t trust mRNA vaccines after the rushed COVID-19 injections were all but forced on the public. Perhaps if the science goes in a more favorable direction, people will start to actually trust thsoe who are right now, only making money off of ailments and sicknesses.

Read the full article here

You Might Also Like

ShopTalk Sunday: The Tale of Two Mowings

Artificial Intelligence Is ELIMINATING Jobs On Wall Street

Robber With Stun Gun Meets Brave Clerk | Active Self Protection

Secret Plan by U.S. and Israel to Seize Al-Aqsa Custodianship From Jordan Exposed

Fed Up Hero Runs Over Robbers

Share This Article
Facebook Twitter Email Print
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

We Recommend

CRY HAVOC OFFICIAL TRAILER

JackCarrUSA JackCarrUSA September 12, 2026
Danger Close | Peter Bergen
Why is Full-auto Illegal?
Amazon Sells NOW – 10 ULTIMATE Home Defense Weapons!
Two Permits, Zero Recognition: Long-Haul Trucker Asks Supreme Court to Strike Down Minnesota’s Refusal to Honor His Florida and Georgia Carry Licenses
Third Circuit Rejects New Jersey’s ‘Catch-22’ and Revives NSSF Challenge to Gun Industry Liability Law After State Sued Glock
How to CARRY YOUR KNIFE for SELF DEFENSE #selfdefense #knife #tacticalrifleman  #shorts
Videos

How to CARRY YOUR KNIFE for SELF DEFENSE #selfdefense #knife #tacticalrifleman #shorts

Tactical Rifleman Tactical Rifleman September 11, 2026
Home Invasion? Here’s What You Should Do | Tactical RIfleman
Videos

Home Invasion? Here’s What You Should Do | Tactical RIfleman

Tactical Rifleman Tactical Rifleman September 11, 2026
Daytime Home Invasion Halted As Armed Resident Defends Property
Latest News

Daytime Home Invasion Halted As Armed Resident Defends Property

Jim Flanders Jim Flanders September 11, 2026
  • Videos
  • Tactical
  • Latest News
  • Firearms
2024 © Gun Gravy. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?